Aggressive natural killer cell leukemia with hemophagocytic lymphohistiocytosis: a case report
YANG Jing-Hui, ZHOU Qing-Mei, XU Xin-Yu, YAO Xiang-Mei, LUO Yu-Mei, CHEN Qian-Ting, GUO Zheng-Zheng, LI Tian-He
Department of Pediatrics, First People's Hospital of Yunnan Province/Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, China
Abstract A boy, aged 14 years, was admitted due to recurrent cough and expectoration for more than 1 month, with aggravation and fever for 2 days. After admission, he presented with tachypnea and a significant reduction in transcutaneous oxygen saturation, and emergency chest CT examination showed large patchy exudation and consolidation of both lungs. The boy was given tracheal intubation and invasive mechanical ventilation immediately, and his condition was improved after active symptomatic treatment. On the 10th day of hospitalization, the boy experienced fever again, and the laboratory tests showed positive results for Epstein-Barr virus and Mycoplasma antibody IgM, along with pancytopenia, elevated triglycerides, decreased fibrinogen, and increased levels of ferritin and soluble CD25. The boy was diagnosed with hemophagocytic lymphohistiocytosis. Bone marrow biopsy showed the presence of atypical lymphocytes, and aggressive natural killer cell leukemia was considered according to clinical manifestations and flow cytometry immunophenotype. Therefore, the possibility of hemophagocytic lymphohistiocytosis should be suspected in case of severe infection with pancytopenia and rapid disease progression, and hematological malignancies should also be ruled out. Bone marrow biopsy should be performed as early as possible to make a confirmed diagnosis and perform timely treatment.
YANG Jing-Hui,ZHOU Qing-Mei,XU Xin-Yu et al. Aggressive natural killer cell leukemia with hemophagocytic lymphohistiocytosis: a case report[J]. CJCP, 2024, 26(11): 1225-1230.
YANG Jing-Hui,ZHOU Qing-Mei,XU Xin-Yu et al. Aggressive natural killer cell leukemia with hemophagocytic lymphohistiocytosis: a case report[J]. CJCP, 2024, 26(11): 1225-1230.
Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124-131. PMID: 16937360. DOI: 10.1002/pbc.21039.
Tabata C, Tabata R. Possible prediction of underlying lymphoma by high sIL-2R/ferritin ratio in hemophagocytic syndrome[J]. Ann Hematol, 2012, 91(1): 63-71. PMID: 21523380. DOI: 10.1007/s00277-011-1239-7.
Asaulenko ZP, Spiridonov IN, Baram DV, et al. WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): myeloid and histiocytic tumors[J]. Arkh Patol, 2023, 85(5): 36-44. PMID: 37814848. DOI: 10.17116/patol20238505136.
Sumbly V, Vest M, Landry I. Aggressive natural killer cell leukemia: a brief overview of its genomic landscape, histological features, and current management[J]. Cureus, 2022, 14(2): e22537. PMID: 35345687. PMCID: PMC8956279. DOI: 10.7759/cureus.22537.
